Adytum Impex Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.45 M
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -20.89%
- Profit Growth -56.66%
- Ebitda -312.88%
- Net Worth 3.50%
- Total Assets 0.31%
About Adytum Impex
Adytum Impex Private Limited (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 August 2018 (Six years and six months 18 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Subhendu Guha, Indranil Chakraborty, and Rakesh Das serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999WB2018PTC227361
- Company No.
227361
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Adytum Impex?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhendu Guha  | Director | 19-Jul-2019 | Current |
| Indranil Chakraborty | Director | 10-Aug-2018 | Current |
| Rakesh Das | Director | 10-Aug-2018 | Current |
Financial Performance of Adytum Impex.
Adytum Impex Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.89% decrease. The company also saw a substantial fall in profitability, with a 56.66% decrease in profit. The company's net worth moved up by a moderate rise of 3.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adytum Impex?
In 2021, Adytum Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Path-O-Rad Diagnostic Private LimitedSubhendu Guha is a mutual person
- Suzolang Biochem Private Limited
Indranil Chakraborty is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adytum Impex?
Unlock and access historical data on people associated with Adytum Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adytum Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adytum Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
